^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    Autologous CAR-T cells

    i
    Other names: Autologous CAR-T cells
    Associations

    News

    Trials
    Company:
    UTC Therap
    Drug class:
    CD19-targeted CAR-T immunotherapy, BCMA-targeted CAR-T immunotherapy, CD123-targeted CAR-T immunotherapy, CD7-targeted CAR-T immunotherapy
    Related drugs:
    Associations

    News

    Trials
    1year
    Novel CAR-T Cell Therapy in the Treatment of Hematopoietic and Lymphoid Malignancies (clinicaltrials.gov)
    P1, N=0, Withdrawn, Shanghai Pudong Hospital | N=20 --> 0 | Recruiting --> Withdrawn
    Enrollment change • Trial withdrawal • CAR T-Cell Therapy
    |
    CD19 (CD19 Molecule)
    |
    CD19 expression
    |
    cyclophosphamide • fludarabine IV • Autologous CAR-T cells
    over1year
    Novel CAR-T Cell Therapy in the Treatment of Hematopoietic and Lymphoid Malignancies (clinicaltrials.gov)
    P1, N=20, Recruiting, Shanghai Pudong Hospital
    New P1 trial • CAR T-Cell Therapy
    |
    CD19 (CD19 Molecule)
    |
    CD19 expression
    |
    cyclophosphamide • fludarabine IV • Autologous CAR-T cells